Novel substituted 7-deazapurine ribonucleosides for therapeutic uses
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F16%3A33160577" target="_blank" >RIV/61989592:15110/16:33160577 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=AU&NR=2014277740B1&KC=B1&FT=D&ND=4&date=20160225&DB=&locale=en_EP" target="_blank" >https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=AU&NR=2014277740B1&KC=B1&FT=D&ND=4&date=20160225&DB=&locale=en_EP</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Novel substituted 7-deazapurine ribonucleosides for therapeutic uses
Original language description
The invention provides compounds of formula I, wherein R and R' have values defined in the specification and a pharmaceutically acceptable salt thereof, or an optical isomer thereof, or a mixture of optical isomers, as well as compositions comprising such compounds and therapeutic methods that utilize such compounds and/or compositions.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
AU2014277740 B1
Publisher
AU001 -
Publisher name
IP Australia
Place of publication
Phillip ACT
Publication country
AU - AUSTRALIA
Date of acceptance
Feb 25, 2016
Owner name
ÚOCHB AV ČR, v.v.i.; Univerzita Palackého v Olomouci
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence